Business Name: |
Enantigen Therapeutics Inc |
Contact Person: |
Xiaodong Xu |
Address: |
3805 Old Easton Road, Doylestown, Pennsylvania 18902 |
Phone Number: |
(215) 589-6315 |
Annual Revenue (USD): |
$100.000 to $499.999 |
Founding Year: |
2008 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2B (Business to Business) |
Business Category: |
Research and Development Laboratories |
SIC Code: |
8731 |
NAICS Code: |
541712 |
Share This Business: |
|
Related Businesses: |
Gfree Bio LLC - Doylestown, PA 18902 Fox Chase Chem Diversity Center - Doylestown, PA 18902 Clinical Mobilty Technology - Doylestown, PA 18902 Alliance Discovery Inc - Doylestown, PA 18902 Serome Biosciences - Doylestown, PA 18902 Zasloff Laboratories - Doylestown, PA 18902 Toph Biologicals Inc - Doylestown, PA 18902 Alis Life Science LLC - Doylestown, PA 18902 Als Biopharma LLC - Doylestown, PA 18902 Captivate Pharmaceuticals - Doylestown, PA 18902 Jiffy Lid Technologies LLC - Doylestown, PA 18902 Pennsylvania Drug Discovery Institute - Doylestown, PA 18902 Cherry Pharmaceutical - Doylestown, PA 18902 Jbs Science Inc - Doylestown, PA 18902 Pharmabridge Inc - Doylestown, PA 18902 Immunotope Diagnostics Inc - Doylestown, PA 18902 Shar-X Biopharma LLC - Doylestown, PA 18902 |
The company Enantigen Therapeutics Inc provides B2B services in the form of Research and Development Laboratories from its single location in Pennsylvania.
1 to 4 employees work for Enantigen Therapeutics Inc, and the business now earns $100.000 to $499.999 per annum.
Enantigen Therapeutics Inc was launched in 2008 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Enantigen Therapeutics Inc, please call Xiaodong Xu with the phone number (215) 589-6315 or visit its single location at 3805 Old Easton Road in Doylestown, Pennsylvania 18902.
The location of the single location can also be found using the coordinates 40.333189,-75.12617.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.